Desacylcynaropicrin

Details

Top
Internal ID 6303066b-4a84-49b6-ba66-0b2ed8d4112b
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene lactones > Sesquiterpene lactones > Guaianolides and derivatives
IUPAC Name (3aR,4S,6aR,8S,9aR,9bR)-4,8-dihydroxy-3,6,9-trimethylidene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one
SMILES (Canonical) C=C1CC(C2C(C3C1CC(C3=C)O)OC(=O)C2=C)O
SMILES (Isomeric) C=C1C[C@@H]([C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O)OC(=O)C2=C)O
InChI InChI=1S/C15H18O4/c1-6-4-11(17)13-8(3)15(18)19-14(13)12-7(2)10(16)5-9(6)12/h9-14,16-17H,1-5H2/t9-,10-,11-,12-,13+,14+/m0/s1
InChI Key VPRPYNVJJXOFKZ-SNIKSBKOSA-N
Popularity 25 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H18O4
Molecular Weight 262.30 g/mol
Exact Mass 262.12050905 g/mol
Topological Polar Surface Area (TPSA) 66.80 Ų
XlogP 0.30
Atomic LogP (AlogP) 0.96
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
CHEMBL464877

2D Structure

Top
2D Structure of Desacylcynaropicrin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9866 98.66%
Caco-2 - 0.5704 57.04%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability + 0.7286 72.86%
Subcellular localzation Mitochondria 0.4789 47.89%
OATP2B1 inhibitior - 0.8573 85.73%
OATP1B1 inhibitior + 0.9019 90.19%
OATP1B3 inhibitior + 0.9517 95.17%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.9485 94.85%
P-glycoprotein inhibitior - 0.9245 92.45%
P-glycoprotein substrate - 0.8492 84.92%
CYP3A4 substrate + 0.5267 52.67%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7973 79.73%
CYP3A4 inhibition - 0.8361 83.61%
CYP2C9 inhibition - 0.9320 93.20%
CYP2C19 inhibition - 0.8428 84.28%
CYP2D6 inhibition - 0.9357 93.57%
CYP1A2 inhibition - 0.8231 82.31%
CYP2C8 inhibition - 0.9350 93.50%
CYP inhibitory promiscuity - 0.9097 90.97%
UGT catelyzed + 0.6362 63.62%
Carcinogenicity (binary) - 0.9325 93.25%
Carcinogenicity (trinary) Non-required 0.5141 51.41%
Eye corrosion - 0.8773 87.73%
Eye irritation + 0.7602 76.02%
Skin irritation - 0.5616 56.16%
Skin corrosion - 0.8841 88.41%
Ames mutagenesis - 0.5000 50.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7553 75.53%
Micronuclear - 0.5200 52.00%
Hepatotoxicity + 0.8172 81.72%
skin sensitisation - 0.7351 73.51%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.6000 60.00%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity + 0.6876 68.76%
Acute Oral Toxicity (c) III 0.3534 35.34%
Estrogen receptor binding + 0.5910 59.10%
Androgen receptor binding + 0.5580 55.80%
Thyroid receptor binding - 0.5449 54.49%
Glucocorticoid receptor binding + 0.6748 67.48%
Aromatase binding - 0.7293 72.93%
PPAR gamma - 0.7227 72.27%
Honey bee toxicity - 0.6206 62.06%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.8960 89.60%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.54% 91.11%
CHEMBL308 P06493 Cyclin-dependent kinase 1 91.01% 91.73%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 87.71% 85.14%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.42% 95.56%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.21% 97.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.99% 99.23%
CHEMBL2094127 P06493 Cyclin-dependent kinase 1/cyclin B 84.78% 96.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.85% 89.00%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 81.18% 93.03%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.32% 95.89%

Cross-Links

Top
PubChem 13943205
NPASS NPC187661
ChEMBL CHEMBL464877
LOTUS LTS0037543
wikiData Q105290951